Friday, May 24th, 2024,
14:30-15:30
PSP.01: Z. Ashraf
DEVELOPMENT OF HIGHLY POTENT TYROSINASE INHIBITOR THROUGH COMPUTATIONAL AND WET LAB APPROACHES
PSP.02: J. Yadav, T. Kendell, M. Zupancic, C. Guguta
Nucleation kinetics of Ascorbic acid in aqueous solvents
PSP.03: E. Paszkowska, S. Larsen, P. Klimaszewska, K. Pietrowska, E. Fornal, M. Ciborowski
Statin-induced myalgia – a metabolomics study
PSP.04: D. Chełminiak-Dudkiewicz, M. Macháček, J. Długaszewska, M. Wujak, A. Smolarkiewicz-Wyczachowski, K. Mylkie, M. Ziegler-Borowska
Exploring Levan@CBD biocomposite sponges as cutting-edge, antibacterial wound dressing materials
PSP.05: A. Cherniienko, K. Kossakowski, R. Lesyk, L. Zaprutko, A. Pawełczyk
Optimisation of Quinoxaline Derivatives Synthesis Using Novel Green Analytical Technique of In situ FTIR/Microwave Irradiation Coupled System
PSP.06: K. Strzelecka, A. Kasiński, U. Piotrowska, M. Sobczak, E. Olędzka
Preparation and characterization of poly(amidoamine) dendrimer/camptothecin complex loaded biodegradable nanosystems for potential application in the treatment of non-small cell lung cancer
PSP.07: A. Kiełczyńska, T. Pawiński, P. Szczęsny
The safety and efficacy of mycophenolate mofetil in patients with idiopathic inflammatory myopathies – pilot study
PSP.08: M. Splandesci, M. Dawidowski, V. Manuel Vidal González, F. Salis
Exploring new classes of sulfoximine derivatives of potential biological activity
PSP.09: A. Zielińska, M. Wrzosek
The Anti-Inflammatory Activity of the Aronia melanocarpa Leaves and Flowers
PSP.10: I. Kalinowska, A. Gawalska, M. Stępniewski, P. Zielińska-Świder, E. Burchard, P. Kasprzycka, K. Nowacki, M. Feder
DILOC2 – developing of innovative drug for obesity and diabetes type 2
PSP.11: M. Gajda, B. Kubiak
Electrostatic charging of powder blends with amlodipine besylate and rosuvastatin calcium salt
PSP.12: N. Petryk, R. Meleshko, O. Welchinska, I. Nizhenkovska
Peculiarities of the pharmaceutical analysis of the Clarithromycin substance by the method of high-performance liquid chromatography
PSP.13: K. Wdowiak, A. Miklaszewski, J. Cielecka-Piontek
Amorphous polymer-phospholipid dispersions as a way to co-deliver curcumin and piperine
PSP.14: S. Gajewska, M. Podbielska, A. Ciarkowska, A. Kozakiewicz-Piekarz, M. Marszałł, M. Wujak
Development of efficient system for human adenylate kinase 4 (AK4) production and evaluation of the inhibitory potency of suramin and its derivatives against AK4
PSP.15: M. Włodarczyk, M. Ali, A. Al-Hendy
EFFECT OF EPIGALLOCATECHIN GALLATE AND VITAMIN D ON THE METHYLATION STATUS OF HUMAN UTERINE FIBROID CELLS
PSP.16: N. Diyuk, Y. Holota, None None, D. Lesyk, A. Anisiforova, I. Bodenchuk, V. Zomchak, V. Kosach, P. Borysko, P. Mykhailiuk
Sonidegib bioisosteres: activity and ADME properties
Friday, May 24th, 2024,
15:30-16:30
PPP.01: P. Jesionek, B. Hachuła, D. Heczko, K. Jurkiewicz, M. Tarnacka, M. Zubko, M. Paluch, K. Kamiński, E. Kamińska
The influence of H/D exchange on the thermal and structural properties as well as molecular dynamics (at ambient and high pressure) of the selected active pharmaceutical ingredient
PPP.02: E. Martula, B. Morak-Młodawska, M. Jeleń, P. Okechukwu
Synthesis of new dimers of dipyridothiazines with anticancer action
PPP.03: J. Gubernator, M. Mielecki, M. Ziemniak, R. Borowski, A. Kaczyńska, A. Buczyńska, M. Olejniczak, B. Pająk
A systemic insight into liposomal nanoparticle formulations of annamycin
PPP.04: A. Kaczyńska, M. Ozga, M. Mielecki, R. Borowski, A. Buczyńska, M. Olejniczak, B. Pająk
Anticancer effects of IL-13RA2-targeting cytotoxins – in vitro studies
PPP.05: R. Borowski, A. Kaczyńska, M. Mielecki, A. Buczyńska, M. Olejniczak, B. Pająk
Berubicin – effective drug candidate against primary and metastatic brain tumors
PPP.06: K. Stasiak, B. Grodner
Application of capillary electrophoresis (CE) as an innovative method for determining Bimatoprost, Latanoprost and Travoprost in pharmaceutical preparations.
PPP.07: M. Ceborska, A. Bajdas, K. Kędra
Synthesis and characterization of cocrystals and salts of antifolate pyrimethamine with vanillic acid
PPP.08: P. Nowak, M. Ziegler-Borowska
Magnetic nanoparticles coated with hydrazide starch, as a potential pH-sensitive carrier – synthesis and characterisation
PPP.09: A. Zep, A. Ciesielski, A. Sadocha, A. Rosa, K. Gibuła, M. K. Cyrański, M. Zezula
Co-crystals of genistein with coformers containing N-heterocyclic aromatic unit. Crystal structures, solubility studies, spectral and thermal characterization.
PPP.10: S. Michorowska, N. Korytowska-Przybylska, R. Piotrowski, J. Giebułtowicz
Metabolic Profiling Indicates Predictive Role of Carnitine and Acylcarnitines in Rivaroxaban Efficacy for Thrombus Dissolution in Atrial Fibrillation
PPP.11: S. Michorowska, A. Zięba, J. Giebułtowicz
Optimizing Saliva Metabolomics for Personalized Medicine A Path to Noninvasive Biomarker Discovery, Precision Diagnosis and Therapy Monitoring
PPP.12: K. Stępień, A. Kalicka, J. Giebułtowicz
Quality Assessment of Dietary Supplements Using Liquid Chromatography Coupled with Mass Spectrometry
PPP.13: K. Stępień, D. Myslitska, G. Garbacz, J. Paszkowska, J. Giebułtowicz
The evaluation of the quality of dietary supplements using dissolution test
PPP.14: K. Blicharz-Futera, V. Canale, M. Bijata, M. Stefaniak, G. Satała, D. Warszycki, M. Jastrzębska-Więsek, A. Partyka, R. Kurczab, A. J. Bojarski, J. Włodarczyk, J. K. Lanham, J. D. McCorvy, P. Zajdel
The role of heteroaryl substituents in tuning receptor selectivity and metabolic stability: the case of 5-HT7 receptor inverse agonists with antidepressant activity
PPP.15: O. Michałkiewicz, I. Nowak, I. Rykowska, R. Nowak
Using Multivariate Orthogonal Analysis to Improve the Effectiveness of Preparing Cyclosporine A Modified Daily Disposable Contact Lenses Composed of Hilafilcon B
PPP.16: A. Smolarkiewicz-Wyczachowski, K. Mylkie, K. Kozerska, D. Chełminiak-Dudkiewicz, P. Zimčík, M. Ziegler-Borowska
Magnetic nanoparticles with a chitosan-hemoglobin coating as potential photosensitive PDT drug carriers
PPP.17: K. Mylkie, A. Smolarkiewicz-Wyczachowski, P. Nowak, D. Chełminiak-Dudkiewicz, M. Ziegler-Borowska
Magnetic nanoparticles coated with chitosan enriched in free dihydroxyboryl groups for fast binding of alpha-1-acid glycoprotein
PPP.18: B. Kot, M. Moczulski, A. Kocur, A. Czajkowska, T. Pawiński
POSTER: A simple LC-MS/MS method for determination of calcineurin inhibitors in Mitra™ and Capitainer™ microsampling systems – a pilot comparative study
PPP.19: M. Moczulski, B. Kot, A. Kocur, A. Czajkowska, T. Pawiński
POSTER: HPLC-DAD versus LC-MS/MS methods for (val)ganciclovir therapeutic drug monitoring in clinical practice – comparative study
PPP.20: M. Bamburowicz-Klimkowska, M. Ruzycka-Ayoush, A. Stawarska, I. P. Grudziński
Loading of enzymatic cargo into extracellular vesicles derived from lung cancer cells
PPP.21: M. Ruzycka-Ayoush, A. Targonska, K. Sobczak, A. Stawarska, I. P. Grudziński
Large volume production of extracellular vesicles in a hollow fiber bioreactor
PPP.22: J. Rożek, A. Zielińska
The Analysis of Phytochemical Composition of Lady’s Mantle Herb Extracts and Their Bioavailability in Cosmetic Formulations.
PPP.23: M. Sikorska, M. Muszyńska, J. Nowakowska, K. Sobczak, A. Kasprzak, I. P. Grudziński
Biodistribution of magnesium-doped iron oxide nanoparticles in lung cancerous and non-cancerous cells
PPP.24: A. Olędzka, M. Matuszewski, D. Zawadka, M. E. Czerwińska
The potential role of aqueous extract from fruits of Chaenomeles japonica and its post-digestive fractions in human neutrophils
PPP.25: I. Juźwiuk, Z. Korpusik, M. Lewandowski, G. Zyglińska, A. Puszko, M. Wróbel, M. Dawidowski
NOVEL SULFOXIMINE SCAFFOLDS DERIVED FROM STRECKER REACTION
PPP.26: A. Pawełczyk, K. Sowa-Kasprzak, D. Olender, L. Zaprutko
Novel Molecular Consortia of Cannabidiol with Selected Bioactive Carboxylic Acids
PPP.27: K. Sowa-Kasprzak, A. Pawełczyk, D. Olender, L. Zaprutko
Synthesis and cytotoxicity of new hybrid compounds of curcumin
PPP.28: E. Pesta, E. Gilant, K. Buś-Kwaśnik, D. Gądarowska, A. Daniel-Wójcik, I. Mrzyk
Validated LC-MS/MS method for determination of low oral bioavailability of semaglutide in rat plasma: Application to a pharmacokinetic study
PPP.29: E. Gilant, K. Buś-Kwaśnik, E. Pesta, A. Raciborska
Validated LC-MS method for determination of vemurafenib in human plasma: Application to a pharmacokinetic study in juvenile patients
PPP.30: E. Gilant, K. Buś-Kwaśnik, E. Pesta, A. Raciborska
The selectivity and specificity of the method for trametinib determination in human plasma: Application to pharmacokinetic studies in juvenile patients.
PPP.31: A. Pogorzelska, K. Medyńska, M. Mazur, M. Świtalska, J. Wietrzyk, M. Milczarek, K. Wiktorska
Investigating the Impact of Sulforaphane on Triple-Negative Breast Cancer Using In Vitro and In Vivo Models: Insights into Hormetic Effects
PPP.32: E. Stolarczyk, W. Strzempek, M. Zezula, K. Trzcińska, O. Michalak, K. Sidoryk, E. Menaszek, K. Stolarczyk
New thiolated derivatives of natural products – Coated Gold Nanoparticles. Synthesis, characterization and evaluation of its antioxidant and antitumor activities.
PPP.33: M. Milczarek, A. Pogorzelska, M. Świtalska, J. Wietrzyk, M. Mazur, K. Wiktorska
Anticancer effect of 5-fluorouracil and sulforaphane combined treatment in in vivo model of triple-negative breast cancer
PPP.34: B. Kołodziejska, A. Pyzik, J. Kopczyńska, M. Kowalczyk, J. Kolmas
Multi-component biocomposites enriched with silver ions and ciprofloxacin for potential use in wound healing
PPP.35: M. Ruzycka-Ayoush, A. Głuchowska, K. Sobczak, A. Stawarska, I. P. Grudziński
The stability studies of exosomes derived from lung cancer cells
PPP.36: J. Sobieraj, K. Strzelecka, D. Janiec, A. Kasiński, E. Olędzka
Preparation and characterization of carmustine-α-cyclodextrin inclusion complexes for potential application in the treatment of high grade glioma
PPP.37: M. Nowacki, R. Ramos, K. Sharko, M. Skóra, M. Dawidowski
The use of sulfoximines in the Kabachnik-Fields and Mannich reactions
PPP.38: M. Kołtun-Jasion, M. Wrzosek, A. Kiss
Comparison of the modulatory effect of arctiin and its aglycone – arctigenin on the production of inflammatory mediators in vitro in macrophage cell model
PPP.39: A. Kocur, A. Mikulska, B. Kot, M. Moczulski, A. Czajkowska, T. Pawiński
POSTER: Novel volumetric microsampling device for methotrexate determination in capillary blood – LC-MS/MS method development and analytical validation
PPP.40: K. Ostrowska, T. Żołek
New derivatives of coumarin as novel potential dual acetylcholinesterase-monoamine oxidases inhibitors against Alzheimer’s disease
PPP.41: J. Dąbrowska, M. Łysiak, T. Krautsova, D. Nosal, J. Rząsa, J. Wolniarska
The effectiveness of antimicrobial preservation for a liquid oral formulation drug product depending on the preservatives used, their concentration and the pH of the preparation
PPP.50: A. B. Witkowska, A. Wołczyńska, E. Stolarczyk
Electrochemistry coupled with High Resolution Mass Spectrometry to Study Nitroso- and Oxidation Products of Drugs with Hydrazone Group
Saturday, May 25th, 2024,
14:00-15:00
PSP.17: H. Kuznietsova, N. Barchenko, I. Chuchvera, Y. Holota, P. Borysko
Establishing the Ischemia-Reperfusion Model in Rats for Chronic Renal Pathology Investigation
PSP.18: A. Powała, T. Żołek
Theoretical analysis of the mechanism of selective action of vitamin D receptor agonists with anticancer activity
PSP.19: K. Powała, T. Żołek
Interactions of agonists and antagonists with the retinoid receptor RARγ studied by molecular modeling
PSP.20: A. Minecka, M. Tarnacka, K. Jurkiewicz, D. Żakowiecki, K. Kamiński, E. Kamińska
Mesoporous Matrices as a Promising New Generation of Carriers for Multipolymorphic Active Pharmaceutical Ingredient Aripiprazole
PSP.21: N. Trotsko, O. M. Demchuk, B. Mirosław, M. Sadczuk, R. Jasiński, M. Długosz
EFFICIENT METHOD OF (S)-NICOTINE SYNTHESIS THROUGH THE STAGES OF MYOSMINE REDUCTION AND ENANTIOMERIC SEPARATION OF NORNICOTINE
PSP.22: P. Majewska, D. Bykowski, K. Pajączkowska, M. Magdycz, L. Mucha, S. Piasecka, M. Barys, T. Han
Application of ReactIR™ and EasyViewer™ probes for the analysis of reaction kinetics during the scale-up process of tadalafil
PSP.23: A. Rzewińska, E. Juszczyk, O. Czerepow-Bielik, K. Mróz, P. Dorożyński
Influence of lactose particle size distribution on the performance of inhaled drug product
PSP.24: W. Silva, G. Eduardo de Souza, R. Victorio Carvalho Guido, C. Roque Duarte Correia, M. Todd
Synthesis of new marinoquinoline derivatives with potential antimalarial activity and determination of their molecular target
PSP.25: K. Piatek, V. Gushchina, S. Guttman, M. Klawatsch, L.E. Wilkinson, N. Kupper, T. Manhardt, J. Basílio, M. Salzmann, K. Milanovic, I. Mesteri, A. Vlasaty, E. Kallay, M. Schepelmann
Strain makes a difference – study on inflammation associated colorectal cancer in mice
PSP.26: A. Maj, S. Michałek, L. Gurba-Bryśkiewicz, W. Maruszak, M. Zagozda, Z. Ochal, K. Dubiel, M. Wieczorek
Development of the sustainable ester to alcohol reduction in the synthesis of a key intermediate for PI3Kδ inhibitor (CPL302415) by Ru-catalyzed hydrogenation and LiAlH4 reduction in batch and flow.
PSP.27: E. Juszczyk, K. Fedko, P. Żero, K. Filip, M. Mroczkiewicz, M. Mach, B. Zygmunt, M. Mikońska, J. Hucz-Kalitowska, M. Choroś, E. Mróz, M. Wieczorek
Formulation development strategy of lipid nanoparticles (LNPs) for intravenous administration of mRNA
PSP.28: M. Popova, O. Saliy
Selection of optimal concentration of Doxycycline hyclate in a composition of Topical Foam Aerosol
PSP.29: A. Śliwińska, A. Pobudkowska
Quinolone chemical modifications and influence on its physicochemical and biological properties
Saturday, May 25th, 2024,
15:00-16:00
PPP.42: O. M. Demchuk, M. Janeczko, M. Masłyk, A. Kurowska, K. Herda, M. Kwaśnik, K. Górka, A. Martyna, B. Foll-Josselin, S. Ruchaud, S. Bach, P. Woliński, R. Jasiński, B. Mirosław, M. Sadczuk, K. Kubiński
Development of a novel family of antifungal agents based on a quinone methide oxime framework
PPP.43: M. Grzelecki, N. Tyburc, K. Paradowska, P. Siudem
QUALITATIVE AND QUANTITATIVE ANALYSIS OF COSMETICAL FORMULATIONS CONTAINING BAKUCHIOL
PPP.44: M. Grzegórska, A. Ciarkowska, M. Mielcarz, O. M. Demchuk, A. Kurowska, K. Herda, M. Sadczuk, A. Kozakiewicz-Piekarz
Searching for guanylate kinase inhibitors from Mycobacterium tuberculosis – a new approach to the fight against tuberculosis
PPP.45: V. Canale, K. Klesiewicz, J. Czekajewska, K. Piska, M. Papież, J. Empel, M. Tomczak, E. Karczewska, P. Zajdel
Antibacterial properties of PZ-1985, novel arylurea derivative of aryloxy(1-phenylpropyl) piperidine, against multidrug-resistant Gram-positive bacteria
PPP.46: M. Majdan, P. Maciąg, A. Stawarska, A. Rogalska, A. Małkowska
Studies on the embryotoxic effect of quinoline yellow in zebrafish
PPP.47: A. Tankiewicz-Kwedlo, K. Pawlak, B. Czartoryska-Arlukowicz, L. Kozlowski, T. Lobacz, M. Koda, M. Borkowska, D. Pawlak
ONCOBREAST-TEST as a Promising Tool in Personalized Medicine
PPP.48: P. Romaniuk, Ł. Pajchel, R. Figat, J. Kolmas
New Phosphosilicate Materials with Remineralizing Properties for Potential Applications in Oral Surgery and Conservative Dentistry
PPP.49: Z. Żelażewska, M. Łazarczyk, M. Marszałek-Grabska, K. Gaweł, A. Corde-Skurska, J. Giebułtowicz, M. Sacharczuk, J. Paszkiewicz, A. Leśniak
Assessment of potential morphine and disulfiram co-treatment toxicity – a consideration for chronic pain therapy
PPP.51: B. Sieroń, M. Kołodziejska, K. Kruk, K. Ostrowska
A new series of coumarin derivatives as serotonin receptor agents – microwave synthesis and biological evaluation
PPP.52: K. Rębis, A. Kocur, M. Moczulski, B. Kot, A. Czajkowska, J. Rubik, T. Pawiński
The novel LC-MS/MS method for mTOR inhibitors (sirolimus and everolimus) determination in human whole blood
PPP.53: A. Ostróżka-Cieślik, B. Dolińska, F. Ryszka
Effect of magnesium ion concentration contained in the composition of preservative fluid on renal function based on studies of biochemical indices in homogenates of isolated porcine grafts
PPP.54: B. Drabińska, J. Kujawski
Structural and spectroscopic properties of the selected azoles with antifungal activity – experimental and theoretical studies
PPP.55: K. Rogut, A. Palubicka, M. Nawrocka, A. Krause, H. Kierońska
Application of Hot Melt Extrusion technology in the development of innovative formulation to control hypertension and prevent the occurrence of cardiovascular diseases
PPP.56: M. Kania, H. Kierońska, A. Krause, J. Lipner, M. Magdycz, A. Pałubicka, I. Pawłowska-Kapusta, S. Piasecka, S. Pikul, M. Tyszkiewicz
Evaluation of food effect in a Phase 1 Clinical Trial for an Investigational Medicinal Product, PKL-021, administered orally to healthy subjects
PPP.57: M. Sochacka, S. Michorowska, K. Piotrowska, S. Osowska, J. Giebułtowicz
Application of Untargeted Analysis to Detect Markers of Oxidative Changes in AIO
PPP.58: M. Jędrzejewski, Ł. Szeleszczuk, D. Pisklak
Bacterial CamA methyltransferase as a novel drug target: elucidating enzymatic catalysis using a computational approach
PPP.59: N. Korytowska-Przybylska, R. Piotrowski, J. Giebułtowicz
Comparative Analysis of Antazoline Metabolites: In Vivo versus Electrochemical Detection
PPP.60: O. Czerepow-Bielik, M. Kaza, K. Jarus-Dziedzic, D. Włodarczyk, A. Gierczak-Pachulska, P. Żero, A. Segiet-Święcicka, D. Rabczenko, P. J. Rudzki, M. Wieczorek
Effect of food on pharmacokinetics of drug candidate CPL409116 and its M3 metabolite in healthy volunteers
PPP.61: K. Sęktas, J. Kulczycki, R. Jorda, M. Perina
Development of Novel Steroidal Androgen Receptor Antagonists
PPP.62: S. Araj, Ł. Szeleszczuk
Physicochemical, theoretical, and structural studies on a novel compound with nootropic activity – Noopept
PPP.63: K. Gałązka, R. Jaźwiec, P. J. Rudzki, M. Wieczorek
Determination of esketamine and its three metabolites in animal plasma – evaluation of specificity
PPP.64: J. Dobosz, D. Myslitska, M. Staniszewska, M. Smoleński, J. Paszkowska, G. Garbacz
Evaluation of disintegration time and spreading ability of the vaginal tablets
PPP.65: J. Dobosz, D. Myslitska, M. Staniszewska, M. Smoleński, J. Paszkowska, G. Garbacz
Novel device for check on the disintegration of solid dosage forms
PPP.66: D. Kułaga, A. Drabczk, P. Zaręba, J. Jaśkowska, J. Chrzan, K. Greber, K. Ciura, D. Plażuk, E. Wielgus
Green-friendly synthesis of 1,3,5-triazine derivatives using a sonochemical protocol
PPP.67: A. Kuźmicz, E. Pindelska, J. Giebułtowicz
New multicomponent crystals of prasterone – structural and pharmaceutical studies
PPP.68: K. Fedko, E. Juszczyk, K. Filip, M. Nazarko, B. Zygmunt, M. Mikońska, H. Cieślak, M. Wieczorek
Exploring the influence of buffers on physiochemical properties and in vitro efficacy of lipid nanoparticles loaded with mRNA
PPP.69: H. Naklicka, Z. Majka, J. Giebułtowicz, E. Pindelska
New furazidine salt – synthesis, structural and pharmaceutical studies
PPP.70: M. Chalecka, D. Kazberuk, J. Hermanowicz, A. Surazynski
THE EFFECT OF KNOCK-OUT THE GENE ENCODING PROLIDASE IN MCF7 BREAST CANCER CELLS (MCF7KO-PEPD)
PPP.71: J. Kulczycki, K. Sęktas
Molecular dynamics study of unique androgen receptor deformation induced by novel pyrrole-containing steroidal antagonists
PPP.72: B. Kózka, K. Bębas, J. Turło, J. Giebułtowicz
Pleurotus ostreatus as a novel strategy for mianserin and mycophenolic acid elimination in wastewater treatment
PPP.73: Ł. Pajchel, M. Brai, K. Ziewiec
Synthesis and physicochemical characterization of new mesoporous silica material/Hydroxyapatite composite for potential use as a drug delivery system
PPP.74: A. Pietracho, S. Cheung
A Suitable Size Exclusion Column for Efficient Adeno-Associated Virus Aggregate Analysis
PPP.75: P. Grygier, K. Pustelny, F. Menezes, M. Jemiola-Rzeminska, P. Suder, G. Dubin, A. Czarna
Advancing Inhibitor Specificity for DYRK1A and DYRK1B: A Targeted Approach
PPP.76: K. Pniak, Ł. Szeleszczuk, J. Kolmas
New multifunctional carrier for local delivery of ipriflavone.
PPP.77: B. Kózka, B. Walczak, G. Nałęcz-Jawecki, J. Giebułtowicz
Occurrence of Antidepressants in the Sediments Vistula River near the Effluent Point from WWTP in the Warsaw Agglomeration Area
PPP.78: A. Kalicka, A. Kierasińska, J. Giebułtowicz
Assessment of selected quality aspects of falsified medicinal products used in the treatment of thyroid diseases
PPP.79: S. Ward
Using the Cambridge Structural Database in Drug Sciences
PPP.80: Ż. Kusztal, A. Krakowska, M. Luty-Błocho, I. Skiba-Kurek, A. Olechowska-Jarząb, P. Dorożyński
ANTIBACTERIAL EFFECT OF APPLICATION OF SILVER NANOPARTIGLES (AgNPS) AND CEFIDEROCOL
PPP.81: S. Górska-Jakubowska
Testing the biological activity of exopolysaccharides of the medicinal mushroom Lentinula edodes (shiitake mushroom)
PPP.82: D. Wavhal, R. Ostaszewski
The synthesis and activity of 8-substituited coumarin peptidomimetics against mdr bacteria
PPP.83: R. Tomikowska, R. Tomikowski, K. Łapiński, S. Goderski
Determination of purity of active substances for new drugs using new DSC technology